Clínica Baviera, S.A. (BME:CBAV)

Clínica Baviera Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 7, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Cap	975	796	499	375	285	346
Market Cap Growth	34.27%	59.55%	33.08%	31.43%	-17.46%	50.36%
Enterprise Value	995.28	885.63	569.7	342.95	357.24	426.82
Last Close Price	60.60	49.70	31.20	23.00	17.50	21.20

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 7, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	21.18	19.26	12.63	10.41	9.67	12.62
Forward PE	-	11.01	11.01	11.01	9.86	23.87
PEG Ratio	-	2.65	2.65	2.65	2.47	2.19
PS Ratio	3.04	2.64	1.90	1.67	1.44	2.00
PB Ratio	8.69	3.64	2.58	4.12	2.12	3.17
P/TBV Ratio	5.43	4.45	3.20	5.09	2.39	3.70
P/FCF Ratio	21.04	17.13	13.86	10.67	7.24	9.51
P/OCF Ratio	12.63	10.41	7.98	6.49	5.34	7.39

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 7, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
EV/Sales Ratio	3.10	2.93	2.17	1.52	1.80	2.47
EV/EBITDA Ratio	11.79	10.49	7.44	5.12	6.32	7.97
EV/EBIT Ratio	16.44	14.63	10.23	6.86	8.61	10.83
EV/FCF Ratio	21.49	19.06	15.83	9.76	9.06	11.75

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 7, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Debt / Equity Ratio	0.61	0.61	0.58	0	1.11	1.44
Debt / EBITDA Ratio	1.12	1.12	1.04	0.27	1.95	2.11
Debt / FCF Ratio	2.03	2.03	2.21	0.51	2.79	3.10
Net Debt / Equity Ratio	0.40	0.40	0.36	-0.37	0.53	0.74
Net Debt / EBITDA Ratio	1.05	1.05	0.91	-0.50	1.26	1.50
Net Debt / FCF Ratio	1.91	1.91	1.92	-0.95	1.80	2.21
Asset Turnover	1.31	1.31	1.34	1.37	1.40	1.36
Inventory Turnover	46.59	46.59	46.27	49.66	47.16	47.02
Quick Ratio	0.09	0.09	0.21	1.20	1.03	1.00
Current Ratio	0.97	0.97	0.95	1.28	1.09	1.06
Return on Equity (ROE)	41.02%	41.02%	43.16%	45.73%	48.72%	55.70%
Return on Assets (ROA)	18.82%	18.82%	20.94%	22.51%	21.66%	22.23%
Return on Invested Capital (ROIC)	27.14%	23.56%	36.10%	37.32%	22.36%	21.08%
Return on Capital Employed (ROCE)	34.86%	34.86%	37.79%	41.26%	40.09%	42.28%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 7, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Earnings Yield	4.71%	5.19%	7.92%	9.61%	10.34%	7.92%
FCF Yield	4.75%	5.84%	7.21%	9.37%	13.82%	10.51%
Dividend Yield	2.58%	3.32%	5.19%	3.62%	6.02%	5.02%
Payout Ratio	52.82%	62.78%	64.39%	37.73%	58.23%	63.34%
Buyback Yield / Dilution	-0.13%	-0.08%	1.85%	0.00%	0.00%	-0.01%
Total Shareholder Return	2.46%	3.24%	7.04%	3.62%	6.02%	5.01%

Data Source: Fiscal.ai Last updated: Feb 28, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 5, 2026

Data Sources Report a data error